Skip to main content

What the FDA labels say about taking them together

Efavirenz and warfarin

Efavirenz's FDA label of March 31, 2024 names warfarin in its drug interactions section, and warfarin's label names efavirenz too. The efavirenz label: “Monitor international normalised ratio (INR) and adjust warfarin dosage if necessary.”

Check it at the source: the efavirenz FDA label on DailyMed (effective March 31, 2024, Cipla USA Inc.); the warfarin FDA label on DailyMed (effective May 29, 2026, Amneal Pharmaceuticals LLC).

What does the efavirenz label say about warfarin?

Efavirenz label, drug interactions

Concomitant Drug Class/Drug Name: Anticoagulant:Warfarin; Effect: ↑ or ↓ warfarin; Clinical Comment: Monitor international normalised ratio (INR) and adjust warfarin dosage if necessary.

Source: FDA drug label (Efavirenz), Cipla USA Inc., effective March 31, 2024 (SPL set 92603fa5-7a2c-4bfb-9a70-aadb4fba952c), via openFDA; the full label on DailyMed

What does the warfarin label say about efavirenz?

Warfarin label, drug interactions

… lopinavir/ritonavir, nefazodone, nelfinavir, nilotinib, oral contraceptives, posaconazole, ranitidine, ranolazine, ritonavir, saquinavir, telithromycin, tipranavir, voriconazole, zileuton armodafinil, amprenavir, aprepitant, bosentan, carbamazepine, efavirenz, etravirine, modafinil, nafcillin, phenytoin, pioglitazone, prednisone, rifampin, rufinamide

Source: FDA drug label (Warfarin Sodium), Amneal Pharmaceuticals LLC, effective May 29, 2026 (SPL set 558b7a0d-5490-4c1b-802e-3ab3f1efe760), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

5Efavirenz generic labelers
19Warfarin generic labelers
EfavirenzWarfarin
Labeled forHIVBlood clots (DVT and PE), Atrial fibrillation
Boxed warningNoYes
Pharmacy cost (NADAC)$1.28 per tablet 600 mg tablet$0.093 per tablet 2 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?